 |
| Date |
Name |
Title |
Type |
Shares Traded |
Price Range |
| Apr 5, 2010 |
abercrombie george b |
Director |
Statement of Ownership |
0 |
n/a |
| Apr 5, 2010 |
abercrombie george b |
Director |
Acquisition (Non Open Market) |
25,000 |
n/a |
| Mar 31, 2010 |
brennan murray |
Director |
Acquisition (Non Open Market) |
15,000 |
n/a |
| Mar 31, 2010 |
cannon james anthony |
Director |
Acquisition (Non Open Market) |
15,000 |
n/a |
| Mar 31, 2010 |
fowler wyche |
Director |
Acquisition (Non Open Market) |
15,000 |
n/a |
| Mar 31, 2010 |
fragin gary s |
Director |
Acquisition (Non Open Market) |
15,000 |
n/a |
| Mar 31, 2010 |
mcinerney timothy |
Director |
Acquisition (Non Open Market) |
15,000 |
n/a |
| Mar 31, 2010 |
weiser michael |
Director |
Acquisition (Non Open Market) |
15,000 |
n/a |
| Jan 8, 2010 |
lewis jonathan |
Officer |
Disposition (Non Open Market) |
12,650 |
3.10 |
| Dec 31, 2009 |
bagley richard e |
Officer |
Acquisition (Non Open Market) |
50,000 |
n/a |
| Dec 31, 2009 |
brennan murray |
Director |
Acquisition (Non Open Market) |
7,500 |
n/a |
| Dec 31, 2009 |
cannon james anthony |
Director |
Acquisition (Non Open Market) |
7,500 |
n/a |
| Dec 31, 2009 |
fowler wyche |
Director |
Acquisition (Non Open Market) |
7,500 |
n/a |
| Dec 31, 2009 |
fragin gary s |
Director |
Acquisition (Non Open Market) |
7,500 |
n/a |
| Dec 31, 2009 |
lewis jonathan |
Officer |
Acquisition (Non Open Market) |
150,000 |
n/a |
| Dec 31, 2009 |
mcinerney timothy |
Director |
Acquisition (Non Open Market) |
7,500 |
n/a |
| Dec 31, 2009 |
weiser michael |
Director |
Acquisition (Non Open Market) |
7,500 |
n/a |
| Dec 9, 2009 |
cannon james anthony |
Director |
Buy |
175,000 |
3.10 |
| Dec 9, 2009 |
mcinerney timothy |
Director |
Buy |
50,000 |
3.10 |
| Dec 8, 2009 |
essex woodlands health ventures fund vi l p |
Beneficial Owner (10% or more) |
Buy |
129,000 |
3.10 |
|
|
Stock transaction information provided by EDGAR Online.
ZIOPHARM Oncology, Inc. makes no representation or warranty with respect any of to
the information contained herein, takes no responsibility for
supplementing, updating or correcting any such information and shall have
no liability with respect to any such information. This listing does not
include derivatives, such as stock option grants or shares purchased
through an employee stock purchase plan. For recent transactions, including
derivative transactions, see our
Section 16 SEC filings page.
| |
Stock Information
ZIOP - (NASDAQ)
$3.85
+ 0.03
|
Sep 10, 2010
2:16 PM ET |
|
